Abstract
This article provides an overview of the different types of familial hyperlipidaemia that may be encountered in clinical practice, namely, familial combined hyperlipidaemia (FCH) and familial hypercholesterolaemia (FH). Owing to their complexity, apolipoprotein disorders will not be covered. The underlying causes and clinical consequences of FCH and FH will be discussed, in addition to management strategies that can be implemented to mitigate against such consequences of familial hyperlipidaemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
